FULL TEST BANK For Pharmacotherapeutics For Advanced Practice Nurse Prescribers 6th Edition By Teri Moser Woo RN Phd ARNP CPNP-PC CNL FAANP (Author) Latest Update Graded A+

PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE
PRESCRIBERS 6TH EDITION WOO ROBINSON TEST BANK




TEST BANK

, PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE CAREGIVER PRESCRI D9 D9 D9 D9 D9




BERS 6TH EDITION WOO ROBINSON TEST BANK D9 D9 D9 D9 D9 D9




CH 1. The Role of the Caregiver Practit
D9D9 D9 D9 D9 D9 D9 D9




ionerMultiple selection
9
D D9




Identify the option that best completes the statement or answers the question.
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9




D9 1. Nurse practitioner prescriptive authority is regulated by:
D9 D9 D9 D9 D9 D9 D9


1. The National Council of State Boards of Nursing
D9 D9 D9 D9 D9 D9 D9


2. The U.S. Medical drug Enforcement Administration
D9 D9 D9 D9 D9


3. The State Board of Nursing for each state
D9 D9 D9 D9 D9 D9 D9


4. The State Board of PharmacyD9 D9 D9 D9



D9


2. The benefits to the hospital client of having an Advanced Practice Registered C
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


aregiver (APRN) prescriberinclude:
D9 D9 D
9


1. Caregivers know more about Pharmacology than other prescribers beca
D9 D9 D9 D9 D9 D9 D9 D9


use they take itboth in their basic nursing program and in their APRN p
D9 D9 D9 D
9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


rogram.
2. Caregivers care for the hospital client from a holistic approach and
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D


include the hospital client indecision making regarding their care.
9 D9 D9 D9 D9 D
9 D9 D9 D9 D9


3. APRNs are less likely to prescribe narcotics and other controlled substances.
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


4. APRNs are able to prescribe independently in all states, whereas a p
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


hysician’sassistant needs to have a physician supervising their practi
D
9 D9 D9 D9 D9 D9 D9 D9 D9


ce.
D9 3. Clinical judgment in prescribing includes:
D9 D9 D9 D9 D9


1. Factoring in the cost to the hospital client of the medication prescribed
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


2. Always prescribing the newest medication available for the disease process
D9 D9 D9 D9 D9 D9 D9 D9 D9


3. Handing out medical drug samples to poor hospital clients
D9 D9 D9 D9 D9 D9 D9 D9


4. Prescribing all generic medications to cut costs D9 D9 D9 D9 D9 D9




D9 4. Criteria for choosing an effective medical drug for a disorder include:
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


1. Asking the hospital client what medical drug they think would work best for them
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


2. Consulting nationally recognized guidelines for disease management
D9 D9 D9 D9 D9 D9


3. Prescribing medications that are available as samples before writing a prescription
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


4. Following U.S. Drug Enforcement Administration guidelines for prescribing
D9 D9 D9 D9 D9 D9 D9




D9 5. Caregiver practitioner practice may thrive under health-care reform because of:
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


1. The demonstrated ability of caregiver practitioners to control costs and i
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


mprove hospital client outcomes D9 D9 D9


2. The fact that caregiver practitioners will be able to practice independently
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


3. The fact that caregiver practitioners will have full reimbursement und
D9 D9 D9 D9 D9 D9 D9 D9 D9


er health-carereformD9 D
9


4. The ability to shift accountability for Medicaid to the state level
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9

,CH 1. The Role of the Caregiver Practit
D9D9 D9 D9 D9 D9 D9 D9


ionerAnswer Section
9
D D9




MULTIPLE SELECTION D9




1. ACC
D9 3 PTS: 1
URATE D9


ANSWE
R:
2. ACC
D9 2 PTS: 1
URATE D9


ANSWE
R:
3. ACC
D9 1 PTS: 1
URATE D9


ANSWE
R:
4. ACC
D9 2 PTS: 1
URATE D9


ANSWE
R:
5. ACC
D9 1 PTS: 1
URATE D9


ANSWE
R:

CH 2. Review of Basic Principles of Pharmacology
D9D9 D9 D9 D9 D9 D9 D9




Multiple selection D9




Identify the option that best completes the statement or answers the question.
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9




D9


1. A hospital client’s nutritional intake and laboratory results reflect hypoalbumin
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


emia. This is critical toprescribing because:
D9 D9 D9 D9 D
9 D9


1. Distribution of medical drugs to target tissue may be affected.
D9 D9 D9 D9 D9 D9 D9 D9 D9


2. The solubility of the medical drug will not match the site of absorption.
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


3. There will be less free medical drug available to generate an effect.
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


4. Medical drugs bound to albumin are readily excreted by the kidneys.
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9




D9 2. Medical drugs that have a significant first-pass effect:
D9 D9 D9 D9 D9 D9 D9 D9


1. Must be given by the enteral (oral) route only
D9 D9 D9 D9 D9 D9 D9 D9


2. Bypass the hepatic circulation D9 D9 D9


3. Are rapidly metabolized by the liver and may have little if any desired action
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


4. Are converted by the liver to more active and fat-soluble forms
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9




D9 3. The route of excretion of a volatile medical drug will likely be the:
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


1. Kidneys
2. Lungs
3. Bile and feces D9 D9


4. Skin

, D9


4. Medroxyprogesterone (Depo Provera) is prescribed intramuscularly (IM) to c
D9 D9 D9 D9 D9 D9 D9 D9 D9


reate a storagereservoir of the medical drug. Storage reservoirs:
D9 D9 D
9 D9 D9 D9 D9 D9 D9


1. Assure that the medical drug will reach its intended target tissue
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


2. Are the reason for giving loading doses
D9 D9 D9 D9 D9 D9


3. Increase the length of time a medical drug is available and active
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


4. Are most common in collagen tissues
D9 D9 D9 D9 D9




D9


5. The NP chooses to give cephalexin every 8 hours based on knowledge of the medical drug’s:
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


1. Propensity to go to the target receptor D9 D9 D9 D9 D9 D9


2. Biological half-life D9


3. Pharmacodynamics
4. Safety and side effects D9 D9 D9




6. Azithromycin dosing requires that the first day’s dosage be twice those of the
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


other 4 days of theprescription. This is considered a loading dose. A loading dose:
D9 D9 D9 D9 D
9 D9 D9 D9 D9 D9 D9 D9 D9 D9


1. Rapidly achieves medical drug levels in the therapeutic range
D9 D9 D9 D9 D9 D9 D9 D9


2. Requires four- to five-half-lives to attain D9 D9 D9 D9 D9


3. Is influenced by renal function
D9 D9 D9 D9


4. Is directly related to the medical drug circulating to the target tissues
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9



D9


7. The point in time on the medical drug concentration curve that indicates the first
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D


sign of a therapeutic effectis the:
9 D9 D9 D9 D9 D
9 D9


1. Minimum adverse effect level D9 D9 D9


2. Peak of action D9 D9



3. Onset of action D9 D9


4. Therapeutic range D9




D9 8. Phenytoin requires that a trough level be drawn. Peak and trough levels are done:
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


1. When the medical drug has a wide therapeutic range
D9 D9 D9 D9 D9 D9 D9 D9


2. When the medical drug will be administered for a short time only
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


3. When there is a high correlation between the dose and saturation of receptor sites
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


4. To determine if a medical drug is in the therapeutic range
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9



D9


9. A laboratory result indicates that the peak level for a medical drug is above the minimum to
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


xic concentration.
D9


This means that the: D9 D9 D9


1. Concentration will produce therapeutic effects D9 D9 D9 D9


2. Concentration will produce an adverse response D9 D9 D9 D9 D9


3. Time between doses must be shortened D9 D9 D9 D9 D9


4. Duration of action of the medical drug is too long D9 D9 D9 D9 D9 D9 D9 D9 D9




D9 D9D9 10. Medical drugs that are receptor agonists may demonstrate what property?
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9


1. Irreversible binding to the medical drug receptor site D9 D9 D9 D9 D9 D9 D9


2. Upregulation with chronic use D9 D9 D9


3. Desensitization or downregulation with continuous use D9 D9 D9 D9 D9


4. Inverse relationship between medical drug concentration and medical drug action
D9 D9 D9 D9 D9 D9 D9 D9 D9




D9 D9D9 11. Medical drugs that are receptor antagonists, such as beta blockers, may cause:
D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9 D9